Buscar
Cryo-Cell International Inc
CCELAñadir a la lista de seguimiento
3.420USD
+0.070+2.08%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
27.55MCap. mercado
PérdidaP/E TTM
Más Datos de Cryo-Cell International Inc Compañía
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Información de Cryo-Cell International Inc
Símbolo de cotizaciónCCEL
Nombre de la empresaCryo-Cell International Inc
Fecha de salida a bolsaApr 04, 1994
Director ejecutivoPortnoy (Mark L)
Número de empleados82
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 04
Dirección700 Brooker Creek Blvd
CiudadOLDSMAR
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal34677
Teléfono18137492104
Sitio Webhttps://www.cryo-cell.com/
Símbolo de cotizaciónCCEL
Fecha de salida a bolsaApr 04, 1994
Director ejecutivoPortnoy (Mark L)
Ejecutivos de Cryo-Cell International Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cryo-Cell International Inc?
Los cinco principales accionistas de Cryo-Cell International Inc son: Mr. David I. Portnoy
¿Cuántas instituciones poseen acciones de Cryo-Cell International Inc (CCEL)?
A fecha de 2026Q1, 36 instituciones poseen acciones de Cryo-Cell International Inc, con un valor de mercado combinado de aproximadamente 1.00M, lo que representa el 12.47% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -82390.00.
¿Cuál es la mayor fuente de ganancias de Cryo-Cell International Inc?
El 2026Q1, el segmento empresarial Processing and storage fees generó la ganancia más alta para Cryo-Cell International Inc, ascendiendo a 31.38M y representando el 99.42% de la ganancia total.